Articles with "extended release" as a keyword



Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Pharmacology in Drug Development"

DOI: 10.1002/cpdd.1089

Abstract: Most stimulants used to treat attention‐deficit/hyperactivity disorder are administered in the morning and absorbed in the upper gastrointestinal tract. DR/ER‐MPH (formerly HLD200), an evening‐dosed delayed‐release and extended‐release methylphenidate, is predicted to be absorbed in the… read more here.

Keywords: formulation; release; release methylphenidate; extended release ... See more keywords

Model‐Informed Development and Registration of a Once‐Daily Regimen of Extended‐Release Tofacitinib

Sign Up to like & get
recommendations!
Published in 2017 at "Clinical Pharmacology and Therapeutics"

DOI: 10.1002/cpt.576

Abstract: Extended‐release (XR) formulations enable less frequent dosing vs. conventional (e.g., immediate release (IR)) formulations. Regulatory registration of such formulations typically requires pharmacokinetic (PK) and clinical efficacy data. Here we illustrate a model‐informed, exposure–response (E‐R) approach… read more here.

Keywords: tofacitinib; extended release; model informed; registration ... See more keywords

Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings

Sign Up to like & get
recommendations!
Published in 2025 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.70085

Abstract: To assess whether exposure to an extended‐release (ER) oxycodone with abuse deterrent properties (ADF) reduced tampering of oxycodone in a real‐world, postmarket setting to address the thinking behind Category 4 labeling by the FDA. read more here.

Keywords: oxycodone; deterrent properties; abuse deterrent; extended release ... See more keywords

Extended release versus immediate release tacrolimus in kidney transplant recipients: a systematic review and meta-analysis

Sign Up to like & get
recommendations!
Published in 2018 at "European Journal of Clinical Pharmacology"

DOI: 10.1007/s00228-018-2512-7

Abstract: PurposeTo compare the estimated glomerular filtration rate (eGFR) at 12 months together with other outcomes among adult kidney transplant recipients (KTRs) who received extended release, once daily tacrolimus (ER-Tac) compared to those who received the immediate… read more here.

Keywords: extended release; immediate release; kidney transplant; transplant recipients ... See more keywords

Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study

Sign Up to like & get
recommendations!
Published in 2017 at "Cardiovascular Drugs and Therapy"

DOI: 10.1007/s10557-017-6737-y

Abstract: BackgroundPlasma high triacylglycerols and low HDL-C concentration are associated with increased cardiovascular events. Extended-release nicotinic acid (ERN) was shown to reduce plasma triacylglycerols and total cholesterol but also to markedly increase high-density lipoprotein-cholesterol (HDL-C). No… read more here.

Keywords: extended release; spectrometry; mass spectrometry; analysis ... See more keywords

Exploring the use of extended release opioids at shortened dosing intervals in people with chronic pain and high risk medication or substance use

Sign Up to like & get
recommendations!
Published in 2020 at "International Journal of Clinical Pharmacy"

DOI: 10.1007/s11096-020-01027-y

Abstract: Background Critical attention to rational opioid prescribing has emerged from the opioid epidemic in North America. Individuals with chronic pain are prescribed extended release opioids in an effort to maintain stable drug levels and for… read more here.

Keywords: use; extended release; release opioids; chronic pain ... See more keywords

Perfluorodecalin allows resuspension and prevents sediment solidification of extended-release drug formulations in primary packaging

Sign Up to like & get
recommendations!
Published in 2024 at "Drug Delivery and Translational Research"

DOI: 10.1007/s13346-024-01598-7

Abstract: In this technical note we show with two simple experiments how Perfluorodecalin (PFD), an injectable perfluorocarbon, can be used as an agent for resuspending microparticulate suspensions in primary packaging containers for injection. Furthermore, we explain… read more here.

Keywords: sediment solidification; extended release; resuspension; primary packaging ... See more keywords
Photo from wikipedia

Onapristone Extended Release: Safety Evaluation from Phase I–II Studies with an Emphasis on Hepatotoxicity

Sign Up to like & get
recommendations!
Published in 2020 at "Drug Safety"

DOI: 10.1007/s40264-020-00964-x

Abstract: Introduction Antiprogestins have demonstrated promising activity against breast and gynecological cancers, but liver-related safety concerns limited the advancement of this therapeutic class. Onapristone is a full progesterone receptor antagonist originally developed as an oral contraceptive… read more here.

Keywords: phase studies; safety; onapristone; extended release ... See more keywords

An approach to natural insect repellent formulations: from basic research to technological development.

Sign Up to like & get
recommendations!
Published in 2020 at "Acta tropica"

DOI: 10.1016/j.actatropica.2020.105419

Abstract: The incidence of dengue, Zika, chikungunya, yellow fever and malaria cases has increased significantly in the world. To avoid mosquito bites, one of the best strategies is the use of repellents. The interest in using… read more here.

Keywords: research; extended release; repellent activity; repellent formulations ... See more keywords

Role of hydroxypropylmethylcellulose (HPMC 4000) in the protection of the polymorphs of Piroxicam extended release tablets

Sign Up to like & get
recommendations!
Published in 2017 at "Arabian Journal of Chemistry"

DOI: 10.1016/j.arabjc.2013.03.005

Abstract: Abstract The present study deals with the influence of hydroxypropylmethylcellulose 4000 in the protection of Piroxicam polymorphs which could appear during the processes of formulation of extended release tablets. The physico-chemical tests and the dissolution… read more here.

Keywords: extended release; piroxicam; release tablets; 4000 protection ... See more keywords

A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults.

Sign Up to like & get
recommendations!
Published in 2017 at "Clinical therapeutics"

DOI: 10.1016/j.clinthera.2017.07.006

Abstract: PURPOSE There is a strong association between attention-deficit/hyperactivity disorder (ADHD) and alcohol abuse, yet no studies have systematically assessed the effect of alcohol on the pharmacokinetics of psychostimulants such as amphetamine (AMP) in vivo. This… read more here.

Keywords: amp; extended release; study; effect alcohol ... See more keywords